Neoadjuvant FOLFIRINOX Versus Upfront Surgery for Resectable Pancreatic Head Cancer (NORPACT-1): a Multicentre, Randomised, Phase 2 Trial.
Knut Jorgen Labori,Svein Olav Bratlie,Bodil Andersson,Jon-Helge Angelsen,Christina Biorserud,Bergthor Bjornsson,Erling Audun Bringeland,Nils Elander,Herish Garresori,Jon Erik Gronbech,Johan Haux,Oskar Hemmingsson,Maria Gustafsson Liljefors,Tor Age Myklebust,Linn Save Nymo,Katriina Peltola,Per Pfeiffer,Ville Sallinen,Per Sandstrom,Ernesto Sparrelid,Helge Stenvold,Kjetil Soreide,Bobby Tingstedt,Caroline Verbeke,Daniel Ohlund, Leif Klint,Svein Dueland,Kristoffer Lassen LANCET GASTROENTEROLOGY & HEPATOLOGY(2024)
关键词
Neoadjuvant Therapy,Pancreatic Neuroendocrine Tumors
AI 理解论文
溯源树
样例
